Mental Process – Page 5

Alligator Bioscience Slashes 70% of Workforce Due to Financial Strains

5 months ago talkbio0Tagged Alligators, Biopharma, Bioscience, Capital, constraints, Financial Stress, Industry, Staff

Alligator Bioscience, staff cuts, capital constraints, biopharma industry, financial challenges

Outlook Therapeutics to Resubmit BLA for ONS-5010 Despite Missing Primary Endpoint in NORSE EIGHT Trial

5 months ago talkbio0Tagged AMD, Approved, Attitude, Biologics License Application, Glycogen storage disease type II, Lytenava, New-onset refractory status epilepticus, United States Food and Drug Administration, Wet Age-Related Macular Degeneration

Outlook Therapeutics, ONS-5010, Lytenava, Wet Age-Related Macular Degeneration (wet AMD), Biologics License Application (BLA), NORSE EIGHT Trial, FDA Approval

Outlook Therapeutics Stock Crashes Following Clinical Trial Failure for Wet AMD Therapy

5 months ago talkbio0Tagged AMD, Attitude, Clinical Trials, Failure (biologic function), File (record), Glycogen storage disease type II, OTLK, Prices, United States Food and Drug Administration

Outlook Therapeutics, OTLK, stock price, clinical trial failure, wet AMD therapy, ONS-5010, FDA filing

Novartis CEO Reveals Strategic Pipeline Reduction by 40% Based on Data-Driven Insights

5 months ago talkbio0Tagged clinical pipeline, Data-Driven, Decision, Drug Industry, Novartis, strategic reduction

Novartis, clinical pipeline, data-driven decisions, pharmaceutical industry, strategic reduction

Lawmakers Scrutinize Pharma’s Telehealth Marketing Tactics Amid Concerns Over Patent Abuse and High Drug Prices

5 months ago talkbio0Tagged Drug Industry, drug price, Lawmaker scrutiny, Patent Abuse, Pharma telehealth programs, Practice Experience

Pharma telehealth programs, Patent abuse, High drug prices, Lawmaker scrutiny, Pharmaceutical industry practices

Citizen Health Secures $14.5M in Seed Funding to Revolutionize Rare Disease Care with AI-Powered Data Platform

5 months ago talkbio0Tagged AI-Powered Data Platform, Chan, Citizen, Health, Health care facility, Initiative, Personalized, Plant seeds, Rare Disease Care, Zuckerberg

Citizen Health, Rare Disease Care, AI-Powered Data Platform, Seed Funding, Chan Zuckerberg Initiative, Personalized Healthcare

Neurogene Halts Development of Batten Gene Therapy NGN-101 Following FDA Denial

5 months ago talkbio0Tagged Denial (Psychology), disease research, gene therapy, Infrequent, Juvenile Neuronal Ceroid Lipofuscinosis, Neurogene, NGN-101, United States Food and Drug Administration

Neurogene, Batten disease, gene therapy, NGN-101, FDA denial, rare disease research

Cybin’s Psychedelic Breakthroughs: Advancing Mental Health Treatments

5 months ago talkbio0Tagged Breakthrough Therapy, Clinical Trials, Cybin, Hallucinogens, Identifier, mental health, N,N-Dimethyltryptamine, Psilocybin, United States Food and Drug Administration

Cybin, psychedelic therapeutics, mental health treatments, deuterated psilocybin, deuterated DMT, clinical trials, FDA Breakthrough Therapy Designation.